Nihon Kohden (OTCMKTS:NHNKY) Posts Quarterly Earnings Results

Nihon Kohden (OTCMKTS:NHNKYGet Free Report) issued its earnings results on Thursday. The company reported $0.16 EPS for the quarter, Zacks reports. Nihon Kohden had a net margin of 7.78% and a return on equity of 9.28%.

Nihon Kohden Stock Performance

Shares of OTCMKTS NHNKY traded down $0.10 during midday trading on Thursday, reaching $11.10. 2,414 shares of the company’s stock were exchanged, compared to its average volume of 28,603. Nihon Kohden has a 52-week low of $9.23 and a 52-week high of $17.28. The business’s fifty day moving average price is $10.98 and its two-hundred day moving average price is $11.40. The stock has a market capitalization of $1.90 billion, a PE ratio of 15.20 and a beta of 0.37.

Analysts Set New Price Targets

Separately, UBS Group upgraded Nihon Kohden from a “hold” rating to a “strong-buy” rating in a report on Monday, January 19th. One investment analyst has rated the stock with a Strong Buy rating, According to MarketBeat.com, Nihon Kohden currently has an average rating of “Strong Buy”.

Read Our Latest Analysis on NHNKY

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

See Also

Earnings History for Nihon Kohden (OTCMKTS:NHNKY)

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.